4.7 Article

A Phase 2 Study With a Daily Regimen of the Oral mTOR Inhibitor RAD001 (Everolimus) in Patients With Metastatic Clear Cell Renal Cell Cancer

Related references

Note: Only part of the references are listed.
Article Medicine, General & Internal

Brief communication:: Sirolimus-associated pneumonitis:: 24 cases in renal transplant recipients

L Champion et al.

ANNALS OF INTERNAL MEDICINE (2006)